Justine V Cohen

6PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications.

|Mar 06, 2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.

Sarah A Weiss, Dijana Djureinovic, Wei Wei

|Apr 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma.

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino

|Jan 18, 2024
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.

Takuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas

|Apr 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.

Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder

|Nov 15, 2019
Neurologic complications of melanoma.

Justine V Cohen, Nancy Wang, Vyshak A Venur

Pageof 1

Frequent Collaborators

3 joint publications

Ryan J Sullivan

2 joint publications

Elizabeth I Buchbinder

1 joint publications

Sarah A Weiss

1 joint publications

Dijana Djureinovic